Literature DB >> 28557891

Clinical Presentation and Risk Factors of Venous Thromboembolic Disease.

Sulaiman Alhassan1, Anca Pelinescu, Viral Gandhi, Mouhib Naddour, Anil C Singh, Eric Bihler.   

Abstract

Venous thromboembolism (VTE) has a wide range of clinical presentations. Deep venous thrombosis may occur in upper or lower extremities or in visceral veins. Extremity deep venous thrombosis usually manifests with unilateral painful swelling in the limb, while visceral deep venous thrombosis manifestations vary on the basis of the involved organ. Pulmonary embolism classically manifests with sudden pleuritic chest pain and unexplained dyspnea. Superficial thrombophlebitis usually presents with acute inflammation around a palpable thrombosed superficial vein. Risk factors of VTE are either inherited or acquired. The inherited causes of VTE tend to be familial and more common in younger patients. The common acquired risk factors of VTE include previous history of venous thrombosis, immobilization, recent surgery or trauma, malignancy, and pregnancy. Identifying high-risk patients for VTE based on these risk factors is the cornerstone to provide the prophylactic treatment to prevent thrombotic events.

Entities:  

Mesh:

Year:  2017        PMID: 28557891     DOI: 10.1097/CNQ.0000000000000159

Source DB:  PubMed          Journal:  Crit Care Nurs Q        ISSN: 0887-9303


  2 in total

Review 1.  Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies.

Authors:  Diana-Maria Bunu; Cristian-Eugen Timofte; Manuela Ciocoiu; Mariana Floria; Claudia-Cristina Tarniceriu; Oana-Bogdana Barboi; Daniela-Maria Tanase
Journal:  Gastroenterol Res Pract       Date:  2019-01-13       Impact factor: 2.260

2.  Risk Assessment in Chinese Hospitalized Patients Comparing the Padua and Caprini Scoring Algorithms.

Authors:  Xiaolan Chen; Lei Pan; Hui Deng; Jingyuan Zhang; Xinjie Tong; He Huang; Min Zhang; Jianlin He; Joseph A Caprini; Yong Wang
Journal:  Clin Appl Thromb Hemost       Date:  2018-09-09       Impact factor: 2.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.